Lipid Management Connect
Profile Image
  • Saved


LDL-cholesterol drives reversible myelomonocytic skewing in human bone marrow - PubMed

LDL-cholesterol drives reversible myelomonocytic skewing in human bone marrow - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34508568/

doi: 10.1093/eurheartj/ehab630. Online ahead of print. 1 Institut National de la Santé et de la Recherche Médicale (INSERM) U1065, Université Côte d'Azur, Centre Méditerranéen de Médecine Moléculaire (C3M), Atip-Avenir, Fédération...

Profile Image
  • Saved


Perspectives on Identifying and Treating Familial Hypercholesterolemia in Childhood - PubMed

Perspectives on Identifying and Treating Familial Hypercholesterolemia in Childhood - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34491300/

doi: 10.1093/clinchem/hvab157. Online ahead of print. 1 Department of Cardiology, Boston Children's Hospital, Boston, MA. 2 Dept. of Pediatrics, Harvard Medical School, Boston, MA USA. 3 Richard A. and Susan...

Profile Image
  • Saved


Profile Image
  • Saved


Effects of different doses of atorvastatin on blood lipid level and endothelial function in patients with hypertension and carotid plaque | Chinese Journal of Primary Medicine and Pharmacy;(12): 563-567, 2021. | WPRIM

Source : https://pesquisa.bvsalud.org/portal/resource/pt/wpr-883783

To compare the effects of different doses of atorvastatin on blood lipid and endothelial function in patients with hypertension and carotid plaque. Ninety-two patients with hypertension and carotid plaque who...

Profile Image
  • Saved


Efficacy of intensive lipid-lowering therapy with statins stratified by blood pressure levels in patients with type 2 diabetes mellitus and retinopathy: Insight from the EMPATHY study - Hypertension Research

Efficacy of intensive lipid-lowering therapy with statins stratified by blood pressure levels in patients with type 2 diabetes mellitus and retinopathy: Insight from the EMPATHY study - Hypertension Research

Source : https://www.nature.com/articles/s41440-021-00734-x

Intensive lipid-lowering therapy is recommended in individuals exhibiting type 2 diabetes mellitus (T2DM) with microvascular complications (as high-risk patients), even without known cardiovascular disease (CVD). However, evidence is insufficient to...

Profile Image